Answer
Breastfeeding should be discontinued during treatment with bosutinib monohydrate because a potential risk to the infant cannot be excluded and excretion of bosutinib or its metabolites into human milk is unknown.
Sources for this answer
- Bosulif 500mg Film Coated TabletsPfizer Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 31Document updated
Sources checked